Andrey Mladentsev
Consultant / Advisor at V12 Venture Israel MC Ltd.
Profile
Healthcare professional.
Former VP CIS & Baltics at Stada, CEO at Promomed, CEO at NizhPharm (acquired by Stada), CEO at OBL Pharm (acquired by AFK Sistema).
Andrey Mladentsev active positions
| Companies | Position | Start |
|---|---|---|
V12 Venture Israel MC Ltd.
 V12 Venture Israel MC Ltd. Investment ManagersFinance V12 Venture Israel MC Ltd (V12 Venture Israel) is a venture capital firm founded in 2020. The firm is headquartered in Tel Aviv, Israel. | Consultant / Advisor | - |
Former positions of Andrey Mladentsev
| Companies | Position | End |
|---|---|---|
| STADA ARZNEIMITTEL | Private Equity Investor | 2007-02-28 |
Training of Andrey Mladentsev
| IEDC Bled School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
V12 Venture Israel MC Ltd.
V12 Venture Israel MC Ltd. Investment ManagersFinance V12 Venture Israel MC Ltd (V12 Venture Israel) is a venture capital firm founded in 2020. The firm is headquartered in Tel Aviv, Israel. | Finance |
STADA Arzneimittel AG
 STADA Arzneimittel AG Pharmaceuticals: OtherHealth Technology STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products. It operates through the following segments: Generics, Consumer Healthcare, and Specialty. The Generics segment produces and distributes generic drugs. The Consumer Healthcare segment includes products such as OTC drugs, nutritional supplements and certain consumer healthcare products such as disinfectants and sunscreen. The Specialty segment includes branded generics, specialty generics, and biosimilars. Its brands include Zoflora, Grippostad, Nizoral, and Shampoo & Ladival. The company was founded on March 14, 1895 and is headquartered in Bad Vilbel, Germany. | Health Technology |
- Stock Market
- Insiders
- Andrey Mladentsev
